NCT06135415 2026-01-22
TirbAKare
Almirall, S.A.
Phase 3 Completed
Clinical Trials
8 trialsNCT05741294 2025-02-20
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Almirall, S.A.
Phase 4 Completed
NCT05387525 2025-02-11
AKtive
Almirall, S.A.
Phase 4 Active not recruiting
NCT05260073 2024-09-20
PROAK
Almirall, S.A.
Completed
NCT01074138 2023-02-02
Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer
Athenex, Inc.
Phase 2 Completed
NCT01397799 2015-12-07
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Athenex, Inc.
Phase 1 Completed
NCT01764087 2015-05-18
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1/2 Unknown
NCT00658970 2011-06-08
Evaluation of KX2-391 in Patients With Advanced Malignancies
Athenex, Inc.
Phase 1 Completed